Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15774 articles
High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancer
Serum PRTN3 levels independent poor prognostic factor for progression-free survival.
»
02/02/24
Cardiovascular health assessment in routine cancer follow-up in community settings: survivor risk awareness and perspectives
Many cancer survivors had common cardiovascular comorbidities.
»
01/31/24
Unveiling promising breast cancer biomarkers: an integrative approach combining bioinformatics analysis and experimental verification
Four overexpressed genes ==
CACNG4
,
PKMYT1
,
EPYC
, and
CHRNA6
-- identified.
»
01/31/24
Combining a noble gas with radiotherapy: glutamate receptor antagonist xenon may act as a radiosensitizer in glioblastoma
Indications of radiosensitizing properties of xenon gas in glioblastoma.
»
01/30/24
MicroRNA expression signature as a biomarker in the diagnosis of nodal T-cell lymphomas
Random forest plot modelling capable of distinguishing between RLN and nodal T-cell lymphomas.
»
01/30/24
Baseline Serum Neutrophil-to-Lymphocyte Ratio in Acral Melanoma Compared to Non-Acral Melanoma and its Prognostic Significance.
Advanced-stage ALM exhibited significantly higher baseline NLR.
»
09/24/23
Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study.
POLR2A and KLF4 mutations exclusively occurred in female patients.
»
08/23/23
Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study
Significant difference in favor of APBI.
»
02/03/24
Anoikis-related signature predicts prognosis and characterizes immune landscape of ovarian cancer
Aberrant upregulation of DAPK1 related to poor prognosis.
»
02/03/24
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
Patients with tumors with highest and lowest manually counted HER2 copy number levels had worse RFS.
»
02/07/24
< Prev
Next >